ERBB2 and breast cancer: In the molecular classification of breast cancer, triple-negative breast cancer (estrogen receptor [ER]/ progesterone receptor/human epidermal growth factor receptor-2 [HER2] negative) has a poorer prognosis than other types of breast cancer.